We have found that human non-melanoma skin cancers (squamous cell carcinomas [SCC] and basal cell carcinomas [BCC]) have a missense hot-spot mutation in the BRM gene that is predicted to change amino acid sequence of the protein and inhibit function [5]. The gene discussed is SMARCA2; the disease is skin basal cell carcinoma.